Investing.com - Applied Molecular (NASDAQ: AMTI) reported second quarter EPS of $-0.44, $1.21 worse than the analyst estimate of $0.77. Revenue for the quarter came in at $50M versus the consensus estimate of $25M.
Applied Molecular's stock price closed at $0.29. It is up 6.23% in the last 3 months and down -85.20% in the last 12 months.
Applied Molecular saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Applied Molecular's stock price’s past reactions to earnings here.
According to InvestingPro, Applied Molecular's Financial Health score is "weak performance".
Check out Applied Molecular's recent earnings performance, and Applied Molecular's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar